Notably, tumors with IFNGR1KO treated with control IgG were significantly larger compared to IFNGR1WT treated with control IgG, suggesting a pleiotropic role of IFNGR1 in tumor growth (Fig. 7d). This evidence concerns the gene IFNGR1 and neoplasm.